Neuromuscular disorders - Insights
Learn more about our specialized testing for neuromuscular diseases, including myasthenia gravis, Lambert-Eaton syndrome, and more.
Colorectal and GI Cancer Testing - Mayo Clinic Laboratories
The results and interpretations from our laboratories provide clinically actionable results to guide treatment selection, ensuring every patient receives the medication most appropriate for care.
Breast and Gynecological Cancer - Insights
Learn how our gynecological cancer and breast cancer treatment tests are designed to provide a detailed picture of a patient’s cancer diagnosis.
Leveraging the Laboratory - Insights
A Mayo Clinic podcast for administrators, outreach managers, and laboratory professionals hosted by Jane Hermansen, outreach manager at Mayo Clinic Laboratories, on how to best leverage and optimize the laboratory for patients, clients, and...
Muscle and nerve biopsy consultation - Insights
Our experienced muscle and nerve specialists apply their knowledge to correlate pathological findings with clinical presentation and other testing to confirm specific neuromuscular diseases.
Mitochondrial disease - Insights
Learn about our four molecular testing options, which can be used to confirm a diagnosis and identify a specific mitochondrial syndrome.
Six ways innovative lupus tests are transforming patient and clinician experiences - Insights
The Lupus Foundation of America estimates that at least five million people worldwide have a form of lupus. Yet, the most widely used laboratory tests for patients with this complex condition were developed more than 60 years ago, and...
Hereditary neuromuscular disorders - Insights
Find out how our distinctive approach to evaluating for inherited neuromuscular disorders uses phenotypic information to streamline diagnosis.
B-cell and T-cell acute lymphoblastic leukemia - Insights
Find out how our suite of B-cell and T-cell acute lymphoblastic leukemia tests can detect genetic subgroups and assist in treatment selection.
Find out more about UBA1Q, a quantitative droplet digital polymerase chain reaction (ddPCR) assay that targets seven possible mutations that can occur in the UBA1 gene and help identify VEXAS syndrome.